Metis TechBio seals $1.62b global licensing deal with Boulevard Bio
Hong Kong-listed AI-driven drug delivery innovation company Metis TechBio Co Ltd said on Tuesday it had granted Boulevard Bio, an immunotherapy company backed by healthcare investment firm Deerfield Management, exclusive…